1800-272-662
Shopping Cart 0
countryflagAU
Login

DaVita HealthCare Partners Inc

Healthcare US DVA

151.55USD
-1.01(0.66%)

Last update at 2026-03-10T20:00:00Z

Day Range

149.87154.18
LowHigh

52 Week Range

71.51116.97
LowHigh

Fundamentals

  • Previous Close 152.56
  • Market Cap9767.84M
  • Volume662590
  • P/E Ratio16.60
  • Dividend Yield10.99%
  • EBITDA2217.04M
  • Revenue TTM11911.29M
  • Revenue Per Share TTM131.29
  • Gross Profit TTM 3400.34M
  • Diluted EPS TTM6.44

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Analyst Recommendations

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax 966.28M 1518.49M 1318.26M 1195.44M 1048.48M
Minority interest 221.24M 233.31M -221.03500M -210.31300M -173.64600M
Net income 768.19M 978.45M 773.64M 810.98M 790.08M
Selling general administrative 1355.20M 1195.34M 1247.58M 1103.31M 1135.45M
Selling and marketing expenses - - - - -
Gross profit 3400.34M 3646.38M 3561.99M 3473.99M 3209.34M
Reconciled depreciation 732.60M 680.62M 630.43M 615.15M 591.03M
Ebit 1339.06M 1797.37M 1694.64M 1643.32M 1525.82M
Ebitda 2055.90M 2484.36M 2358.08M 2412.71M 2086.79M
Depreciation and amortization 716.84M 686.99M 663.45M 769.39M 560.97M
Non operating income net other -15.76500M 6.38M 16.76M 29.35M 10.09M
Operating income 1339.06M 1797.37M 1694.64M 1643.32M 1525.82M
Other operating expenses 10297.35M 9848.36M 9866.63M 9632.95M 9914.70M
Interest expense 357.02M 285.25M 304.11M 443.82M 487.44M
Tax provision 198.09M 306.73M 313.93M 279.63M 258.40M
Interest income 357.02M 285.25M 304.11M 443.82M 487.44M
Net interest income -357.01900M -285.25400M -304.11100M -477.22600M -487.43500M
Extraordinary items 13.45M 0.00000M -9.65300M 105.48M -457.03800M
Non recurring - - - 124.89M 13.14M
Other items - - - - -
Income tax expense 198.09M 306.73M 313.93M 279.63M 258.40M
Total revenue 11609.89M 11618.80M 11550.60M 11388.48M 11404.85M
Total operating expenses 2087.80M 1875.95M 1878.02M 1718.46M 1719.19M
Cost of revenue 8209.55M 7972.41M 7988.61M 7914.48M 8195.51M
Total other income expense net -372.78400M -278.87600M -376.37400M -447.87800M -477.34600M
Discontinued operations 13.45M 13.45M -9.65300M 105.48M -457.03800M
Net income from continuing ops 768.19M 1211.76M 1004.33M 915.81M 790.08M
Net income applicable to common shares 560.40M 978.45M 773.64M 810.98M 159.39M
Preferred stock and other adjustments - - - - -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Total assets 16928.25M 17121.49M 16988.52M 17311.39M 19110.25M
Intangible assets 182.69M 177.69M 166.59M 135.68M 95.33M
Earning assets - - - - -
Other current assets 78.84M 165.58M 253.22M 173.21M 3.52M
Total liab 14703.45M 14750.51M 14091.74M 13811.78M 14077.21M
Total stockholder equity 712.33M 755.51M 1383.57M 2133.41M 3703.44M
Deferred long term liab 782.79M 830.95M 809.60M 577.54M 562.54M
Other current liab 730.38M 709.35M 810.53M 756.17M 2498.52M
Common stock 0.09M 0.10M 0.11M 0.13M 0.17M
Capital stock 0.09M 0.10M 0.11M 0.13M 0.17M
Retained earnings 174.49M 354.34M 852.54M 1431.74M 2743.19M
Other liab 888.02M 950.11M 959.66M 738.35M 1013.21M
Good will 7076.61M 7046.24M 6919.11M 6787.64M 6865.48M
Other assets 0.00100M 136.68M 79.50M 91.52M 70.73M
Cash 244.09M 461.90M 324.96M 1102.37M 323.04M
Cash and equivalents 244.09M 461.90M 324.96M 1102.37M 323.04M
Total current liabilities 2619.75M 2398.53M 2476.14M 2372.10M 4891.16M
Current deferred revenue 782.79M 713.75M 693.32M 737.46M -
Net debt 11578.40M 11513.35M 10869.01M 10073.57M 9779.18M
Short term debt 626.80M 573.39M 538.04M 474.62M 1929.37M
Short long term debt 231.40M 179.03M 168.54M 130.71M 1929.37M
Short long term debt total 11822.49M 11975.25M 11193.97M 11175.95M 10102.22M
Other stockholder equity 606.93M 540.32M 597.07M 749.04M 995.01M
Property plant equipment 3256.40M 3479.97M 3521.82M 3473.38M 3393.67M
Total current assets 3155.29M 3167.72M 3148.72M 3690.17M 8424.16M
Long term investments 275.44M 288.39M 289.68M 278.50M 260.04M
Net tangible assets -5198.06300M -5033.59400M -4372.10000M -3609.53400M -2132.72300M
Short term investments 77.69M 22.31M 20.10M 11.57M 2.94M
Net receivables 2550.65M 2410.51M 2438.82M 2305.07M 2397.02M
Long term debt 8692.62M 8729.15M 7917.26M 7977.53M 8172.85M
Inventory 109.12M 107.43M 111.62M 97.95M 107.38M
Accounts payable 479.78M 402.05M 434.25M 403.84M 463.27M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity 163.57M 180.64M 183.19M 185.83M 204.96M
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income -69.18600M -139.24700M -66.15400M -47.49800M -34.92400M
Additional paid in capital - - - - -
Common stock total equity 0.09M 0.10M 0.11M 0.13M 0.17M
Preferred stock total equity - - - - -
Retained earnings total equity 174.49M 354.34M 852.54M 1431.74M 2743.19M
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other -467.20000M -694.27700M -730.09900M -461.57100M -490.95300M
Deferred long term asset charges - - - - -
Non current assets total 13772.96M 13953.76M 13839.79M 13621.22M 10686.09M
Capital lease obligations 2898.47M 3067.07M 3108.17M 3067.71M -
Long term debt total 8692.62M 8729.15M 7917.26M 7977.53M 8172.85M
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Investments -83.60200M -14.69500M -18.95600M -14.64500M 14.45M
Change to liabilities 172.27M -110.49300M 14.66M 146.90M -133.92200M
Total cashflows from investing activities -630.34700M -784.73300M -825.37100M 2995.34M -1005.64300M
Net borrowings -11.27900M 754.25M -63.52900M -2080.19100M 694.78M
Total cash from financing activities -1121.12800M -1082.96600M -1846.77700M -4696.45000M -625.35400M
Change to operating activities 85.87M -14.82000M -20.54500M 145.55M 166.16M
Net income 781.64M 1211.76M 994.68M 1021.29M 333.04M
Change in cash -215.97100M 53.17M -706.92800M 793.30M -103.50000M
Begin period cash flow 554.96M 501.79M 1208.72M 415.42M 518.92M
End period cash flow 338.99M 554.96M 501.79M 1208.72M 415.42M
Total cash from operating activities 1564.57M 1930.88M 1979.03M 2072.36M 1771.64M
Issuance of capital stock - - - - -
Depreciation 732.60M 680.62M 630.43M 615.15M 591.03M
Other cashflows from investing activities 56.68M -128.57300M -131.87400M 3776.53M -32.95100M
Dividends paid 267.95M 244.03M 253.12M 233.12M 196.44M
Change to inventory -0.75700M 5.72M -12.34900M 10.16M 73.50M
Change to account receivables -148.39400M -138.14000M -21.08700M -79.95700M -81.17600M
Sale purchase of stock -839.59500M -1598.62700M -1459.41700M -2383.81600M -1161.51100M
Other cashflows from financing activities 2122.86M 1376.78M 3722.94M 38293.41M 59417.67M
Change to netincome 50.22M 179.14M 346.88M 292.63M 517.52M
Capital expenditures 603.43M 641.47M 674.54M 766.55M 987.14M
Change receivables -120.86100M -9.47900M -100.36400M -77.16700M 155.82M
Cash flows other operating -50.54900M -26.38700M 105.08M 63.39M 234.64M
Exchange rate changes - - - - -
Cash and cash equivalents changes -186.90500M 63.18M -693.12000M 371.25M 140.64M
Change in working capital 0.10M -140.63900M -104.17200M 86.86M 98.90M
Stock based compensation 95.43M 102.21M 91.46M 67.85M 73.06M
Other non cash items 30.47M 16.45M 125.78M 239.48M 401.94M
Free cash flow 961.14M 1289.41M 1304.49M 1305.81M 784.50M

Peer Comparison

Sector: Healthcare Industry: Medical Care Facilities

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
DVA
DaVita HealthCare Partners Inc		 -1.01 0.66% 151.55 16.60 12.12 0.82 8.14 1.72 9.36
HCA
HCA Holdings Inc		 -7.49 1.37% 537.64 13.19 13.66 1.13 293.44 1.77 8.22
FSNUY
Fresenius SE & Co KGaA ADR		 0.05 0.36% 14.02 16.87 9.44 0.42 0.78 0.79 5.37
FSNUF
Fresenius SE & Co. KGaA		 - -% 54.35 16.76 9.62 0.42 0.79 0.78 5.31
JDHIY
JD Health International Inc		 - -% 9.08 62.50 35.97 0.30 2.32 0.16 3.90

Reports Covered

Stock Research & News

View All

Profile

DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company offers integrated care and disease management services to patients in risk-based and other integrated care arrangements; clinical research programs; physician services; and comprehensive kidney care services. Further, it engages in the provision of acute inpatient dialysis services and related laboratory services; and transplant software business. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.

DaVita HealthCare Partners Inc

2000 16th Street, Denver, CO, United States, 80202

Key Executives

Name Title Year Born
Mr. Javier J. Rodriguez CEO & Exec. Director 1971
Mr. Joel Ackerman CFO & Treasurer 1965
Ms. Kathleen Alyce Waters Chief Legal & Public Affairs Officer 1968
Mr. James O. Hearty Chief Compliance Officer 1969
Mr. Michael David Staffieri Chief Operating Officer of Kidney Care 1974
Mr. John D. Winstel Chief Accounting Officer 1971
Mr. Jim Gustafson VP of Investor Relations NA
Mr. Kenneth Gardner Smith Chief People Officer 1981
Mr. Atul Mathur Exec. VP of Global Operations NA
Dr. Abdulkareem Alsuwaida FRCPC, M.D., MSc Chief Medical Officer - Saudi Operations NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.